Examining the Value and Quality of Health Economic Analyses: Implications of Utilizing the QHES
Open accessAbstract
OBJECTIVE: To examine the increasing use of health economic studies and practical implications of evaluating their quality utilizing the Quality of Health Economic Studies (QHES) instrument. METHODS: We first reviewed secondary references to examine ways in which health economic analyses are used in different health care settings, the manner in which these data are appraised and evaluated, and their relevance and value in decision making. The QHES, a new instrument designed to support fast, accurate initial assessments of study quality, was then introduced and validated. A case study was performed using the QHES to score the quality of 30 cost-effectiveness studies in gastroesophageal reflux disease (GERD) published since 1985. Areas where additional research could guide efforts to identify and enhance the use of higher-quality cost-effectiveness studies were suggested. RESULTS: Results from the published validation study of the QHES demonstrated the validity of this new instrument. The resulting QHES scores in the case study of GERD papers ranged from 43 to 91 with a mean of 63.6 (SD=14.7). Approximately 27% of the studies rated had scores less than 50, and 27% had scores above or equal to 75. All 30 studies made conclusions and recommendations and justified them based on their study results. Most studies used appropriate cost and health outcome measures. Very few studies stated the perspective of their analysis and reasons for its selection. The majority of the studies did not perform incremental analysis. CONCLUSION: An examination of the QHES validation study and the case study in GERD suggests that there is a rationale and potential utility to use a quality scoring system for cost-effectiveness studies. The QHES may play an important role in discriminating higher-quality cost-effectiveness information to enhance decision making. The QHES can also serve as a guideline for conducting and reporting future cost-effectiveness studies, as an aid in the editorial process, and for stratification in systematic reviews. Complex decisions regarding resource allocation rarely rely solely on economic considerations but do increasingly use health economic analyses. To the extent that such analyses are used, the QHES may help ensure that higher-quality analyses receive more analytic attention and greater weight in the decision-making process.
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
As per standard practice using QHES, studies were deemed good quality if they attained a score of 75/100 or higher.
“As per standard practice using this framework, the studies were deemed to be of good quality if they attained a score of 75/100 or higher [5].”
From Use of health economic evaluation in the implementation and improvement science fields—a systematic literature review (2019) · cites this paper as [5]
The QHES instrument was designed to more easily tell the difference between high-quality and low-quality studies.
“The QHES instrument was designed to more easily tell the difference between high-quality and low-quality studies [5].”
From Use of health economic evaluation in the implementation and improvement science fields—a systematic literature review (2019) · cites this paper as [5]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Cites
Assessing the quality of reports of randomized clinical trials: Is blinding necessary?
Jadad, A. R., Moore, R. A., Carroll, D., Jenkinson, C., Reynolds, D. J. M., Gavaghan, D. J., & McQuay, H. J. (1996) · Controlled Clinical Trials · doi:10.1016/0197-2456(95)00134-4 · Cited by 17,582 · see citing works
Moher, D., Pham, B., Jones, A., Cook, D. J., Jadad, A. R., Moher, M., Tugwell, P., & Klassen, T. P. (1998) · The Lancet · doi:10.1016/s0140-6736(98)01085-x · Cited by 3,560 · see citing works
Users' guides to the medical literature
Guyatt, G. H. (1993) · JAMA · doi:10.1001/jama.270.17.2096 · Cited by 2,970 · see citing works
Recommendations of the Panel on Cost-Effectiveness in Health and Medicine
Weinstein, M. C. (1996) · JAMA: The Journal of the American Medical Association · doi:10.1001/jama.1996.03540150055031 · Cited by 2,455 · cited 1× · see citing works
“Weinstein et al., 1996.”
The Hazards of Scoring the Quality of Clinical Trials for Meta-analysis
Jüni, P. (1999) · JAMA · doi:10.1001/jama.282.11.1054 · Cited by 1,981 · see citing works
Guidelines for authors and peer reviewers of economic submissions to the BMJ
Drummond, M. F., & Jefferson, T. O. (1996) · BMJ · doi:10.1136/bmj.313.7052.275 · Cited by 1,827 · see citing works
Moher, D., Jadad, A. R., Nichol, G., Penman, M., Tugwell, P., & Walsh, S. (1995) · Controlled Clinical Trials · doi:10.1016/0197-2456(94)00031-w · Cited by 1,308 · see citing works
The Role of Cost-effectiveness Analysis in Health and Medicine
Russell, L. B. (1996) · JAMA: The Journal of the American Medical Association · doi:10.1001/jama.1996.03540140060028 · Cited by 1,167 · see citing works
Are Guidelines Following Guidelines?
Shaneyfelt, T. M., Mayo‐Smith, M. F., & Rothwangl, J. (1999) · JAMA · doi:10.1001/jama.281.20.1900 · Cited by 846 · see citing works
Robinson, R. (1993) · BMJ · doi:10.1136/bmj.307.6907.793 · Cited by 819 · see citing works
Practice guidelines developed by specialty societies: the need for a critical appraisal
Grilli, R. G., Magrini, N., Penna, A., Mura, G., & Liberati, A. (2000) · The Lancet · doi:10.1016/s0140-6736(99)02171-6 · Cited by 663 · see citing works
Panel on cost-effectiveness in health and medicine.
Gold, M. (1996) · PubMed · Cited by 491 · see citing works
Evaluation of Conflict of Interest in Economic Analyses of New Drugs Used in Oncology
Friedberg, M. W. (1999) · JAMA · doi:10.1001/jama.282.15.1453 · Cited by 477 · see citing works
Assessing the Quality of Randomized Controlled Trials:<i>Current Issues and Future Directions</i>
Moher, D., Jadad, A. R., & Tugwell, P. (1996) · International Journal of Technology Assessment in Health Care · doi:10.1017/s0266462300009570 · Cited by 436 · see citing works
Cost-Effectiveness Analysis and the Consistency of Decision Making
George, B., Harris, A., & Mitchell, A. S. (2001) · PharmacoEconomics · doi:10.2165/00019053-200119110-00004 · Cited by 431 · see citing works
Cost-Effectiveness and Cost-Benefit Analyses in the Medical Literature
Udvarhelyi, I. S., Colditz, G. A., Rai, A. K., & Epstein, A. M. (1992) · Annals of Internal Medicine · doi:10.7326/0003-4819-116-3-238 · Cited by 410 · see citing works
Health Economic Guidelines—Similarities, Differences and Some Implications
Hjelmgren, J., Berggren, F., & Andersson, F. (2001) · Value in Health · doi:10.1046/j.1524-4733.2001.43040.x · Cited by 322 · see citing works
Development and Validation of a Grading System for the Quality of Cost-Effectiveness Studies
Chiou, C., Hay, J. W., Wallace, J. F., Bloom, B. S., Neumann, P. J., Sullivan, S. D., Yu, H.-T., Keeler, E. B., Henning, J. M., & Ofman, J. J. (2003) · Medical Care · doi:10.1097/00005650-200301000-00007 · Cited by 308 · see citing works
Self-citationUsers' Guides to the Medical Literature
Drummond, M. (1997) · JAMA · doi:10.1001/jama.1997.03540430064035 · Cited by 303 · see citing works
Clinical Decision Making: From Theory to Practice
Taylor, P. (1996) · JAMA · doi:10.1001/jama.1996.03540170089044 · Cited by 281 · see citing works
The Journal's Policy on Cost-Effectiveness Analyses
Kassirer, J. P., & Angell, M. E. (1994) · New England Journal of Medicine · doi:10.1056/nejm199409083311009 · Cited by 235 · see citing works
Problems With the Interpretation of Pharmacoeconomic Analyses
Hill, S. R., Mitchell, A. S., & Henry, D. A. (2000) · JAMA · doi:10.1001/jama.283.16.2116 · Cited by 227 · see citing works
The Quality of Reporting in Published Cost-Utility Analyses, 1976–1997
Neumann, P. J., Stone, P. W., Chapman, R. H., Sandberg, E. A., & Bell, C. M. (2000) · Annals of Internal Medicine · doi:10.7326/0003-4819-132-12-200006200-00007 · Cited by 208 · see citing works
Self-citationUsers' Guides to the Medical Literature
OʼBrien, B. J. (1997) · JAMA · doi:10.1001/jama.1997.03540460066034 · Cited by 206 · see citing works
Fass, R., Ofman, J. J., Gralnek, I. M., Johnson, C. S., Camargo, E., Sampliner, R. E., & Fennerty, M. B. (1999) · Archives of Internal Medicine · doi:10.1001/archinte.159.18.2161 · Cited by 200 · see citing works
Self-citationEconomic Analysis in Randomized Control Trials
Adams, M. E., McCall, N. T., Gray, D. T., Orza, M. J., & Chalmers, T. C. (1992) · Medical Care · doi:10.1097/00005650-199203000-00005 · Cited by 188 · see citing works
O’Brien, B. J. (1997) · JAMA · doi:10.1001/jama.277.22.1802 · Cited by 162 · see citing works
Heudebert, G. R., Marks, R. D., Wilcox, C. M., & Centor, R. (1997) · Gastroenterology · doi:10.1016/s0016-5085(97)70118-5 · Cited by 152 · see citing works
Guidelines for the clinical and economic evaluation of health care technologies
Guyatt, G. H., Drummond, M., Feeny, D. H., Tugwell, P., Stoddart, G. L., Haynes, R. B., BENNETT, K. J., & Labelle, R. J. (1986) · Social Science & Medicine · doi:10.1016/0277-9536(86)90046-8 · Cited by 144 · see citing works
Cost-utility in practice: A policy maker's guide to the state of the art
Gerard, K. (1992) · Health Policy · doi:10.1016/0168-8510(92)90022-4 · Cited by 141 · see citing works
Health Care CBA and CEA from 1991 to 1996: An Updated Bibliography
Elixhauser, A., Halpern, M. T., Schmier, J. K., & Luce, B. R. (1998) · Medical Care · doi:10.1097/00005650-199805001-00001 · Cited by 136 · see citing works
Canadian Guidelines for Economic Evaluation of Pharmaceuticals
Torrance, G. W., Blaker, D., Detsky, A. S., Kennedy, W. A., Schubert, F., Menon, D., Tugwell, P., Konchak, R., Hubbard, E., & Firestone, T. (1996) · PharmacoEconomics · doi:10.2165/00019053-199609060-00008 · Cited by 129 · see citing works
Gerson, L. B., Robbins, A. S., Garber, A. M., Hornberger, J. C., & Triadafilopoulos, G. (2000) · The American Journal of Gastroenterology · doi:10.1111/j.1572-0241.2000.01759.x · Cited by 115 · see citing works
Saha, S., Hoerger, T. J., Pignone, M. P., Teutsch, S. M., Helfand, M., & Mandelblatt, J. S. (2001) · American Journal of Preventive Medicine · doi:10.1016/s0749-3797(01)00260-4 · Cited by 93 · see citing works
Cost and Quality Effects of Alternative Treatments for Persistent Gastroesophageal Reflux Disease
Hillman, A. L. (1992) · Archives of Internal Medicine · doi:10.1001/archinte.1992.00400190089017 · Cited by 86 · see citing works
Evaluation of Pharmacoeconomic Studies: Utilization of a Checklist
Sacristán, J. A., Soto, J., & Galende, I. (1993) · Annals of Pharmacotherapy · doi:10.1177/106002809302700919 · Cited by 78 · see citing works
Evaluating the BMJ Guidelines for Economic Submissions
Jefferson, T., Smith, R., Yee, Y., Drummond, M., Pratt, M., & Gale, R. (1998) · JAMA · doi:10.1001/jama.280.3.275 · Cited by 72 · see citing works
Eddy, D. M. (1996) · JAMA · doi:10.1001/jama.1996.03530320074047 · Cited by 70 · see citing works
The Trials and Tribulations of Clinical Practice Guidelines
Cook, D. (1999) · JAMA · doi:10.1001/jama.281.20.1950 · Cited by 69 · see citing works
Heudebert, G. R., Centor, R. M., Klapow, J. C., Marks, R. D., Johnson, L. B., & Wilcox, C. M. (2000) · Journal of General Internal Medicine · doi:10.1046/j.1525-1497.2000.02639.x · Cited by 63 · see citing works
Harris, A., Buxton, M. J., OʼBrien, B. J., & Drummond, F. R. A. M. (2001) · Expert Review of Pharmacoeconomics & Outcomes Research · doi:10.1586/14737167.1.1.7 · Cited by 58 · see citing works
The Revised Canadian Guidelines for the Economic Evaluation of Pharmaceuticals
Glennie, J. L., Torrance, G. W., Baladi, J., Berka, C., Hubbard, E., Menon, D., Otten, N., & re, M. R. (1999) · PharmacoEconomics · doi:10.2165/00019053-199915050-00004 · Cited by 52 · see citing works
Harris, R. A., Kuppermann, M., & Richter, J. E. (1997) · PubMed · Cited by 51 · see citing works
The U.K. NHS ECONOMIC EVALUATION DATABASE
Nixon, J., Stoykova, B., Glanville, J., Christie, J., Drummond, M., & Kleijnen, J. (2000) · International Journal of Technology Assessment in Health Care · doi:10.1017/s0266462300102016 · Cited by 49 · see citing works
Use of economic evaluation guidelines: 2 years’ experience in Canada
Baladi, J., Menon, D., & Otten, N. (1998) · Health Economics · doi:10.1002/(sici)1099-1050(199805)7:3 · Cited by 46 · see citing works
Harris, R. A., Kuppermann, M., & Richter, J. E. (1997) · The American Journal of Medicine · doi:10.1016/s0002-9343(96)00301-4 · Cited by 46 · see citing works
Stålhammar, N., Carlsson, J., Peacock, R., Müller-Lissner, S. A., Bigard, M., Porro, G. B., Ponce, J. D. C., Hosie, J., Scott, M. G., Weir, D. G., et al. (1999) · PharmacoEconomics · doi:10.2165/00019053-199916050-00006 · Cited by 46 · see citing works
Kaplan‐Machlis, B. (2000) · Archives of Family Medicine · doi:10.1001/archfami.9.7.624 · Cited by 45 · see citing works
Economic Evaluation of Long Term Management Strategies for Erosive Oesophagitis
Goeree, R. A., Brien, B. O., Hunt, R. H., Blackhouse, G., Willan, A. R., & Watson, J. (1999) · PharmacoEconomics · doi:10.2165/00019053-199916060-00007 · Cited by 43 · see citing works
Mather, D. B., Sd, S., Augenstein, D., Fullerton, D., & Atherly, D. (1999) · PubMed · Cited by 43 · see citing works
The limited incorporation of economic analyses in clinical practice guidelines
Wallace, J. F., Weingarten, S. R., Chiou, C., Henning, J. M., Hohlbauch, A., Richards, M. S., Herzog, N. S., Lewensztain, L. S., & Ofman, J. J. (2002) · Journal of General Internal Medicine · doi:10.1046/j.1525-1497.2002.10522.x · Cited by 37 · see citing works
Self-citationEmerging standardization in pharmacoeconomics
Mullins, C. D., & Ogilvie, S. (1998) · Clinical Therapeutics · doi:10.1016/s0149-2918(98)80115-x · Cited by 37 · see citing works
Resource allocation: beyond evidence-based medicine and cost-effectiveness analysis
SINGER, P. A. (1997) · ACP Journal Club · doi:10.7326/acpjc-1997-127-3-a16 · Cited by 36 · see citing works
The NHS economic evaluation database
Gray, J. M., & Donald, A. (1997) · Evidence-based Healthcare · doi:10.1016/s1462-9410(05)80055-5 · Cited by 36 · see citing works
The FDA's Regulation Of Health Economic Information
Neumann, P. J., Claxton, K., & Weinstein, M. C. (2000) · Health Affairs · doi:10.1377/hlthaff.19.5.129 · Cited by 36 · see citing works
Self-citationMethodological and Conduct Principles for Pharmacoeconomic Research
Clemens, K., Townsend, R., Luscombe, F., Mauskopf, J., Osterhaus, J., & Bobula, J. (1995) · PharmacoEconomics (Auckland) · doi:10.2165/00019053-199508020-00008 · Cited by 35 · see citing works
Eddy, D. M. (1996) · JAMA · doi:10.1001/jama.275.8.650 · Cited by 34 · see citing works
Canada's new guidelines for the economic evaluation of pharmaceuticals.
Menon, D., Schubert, F., & Gw, T. (1996) · PubMed · Cited by 32 · see citing works
Sonnenberg, A., Delcò, F., & El‐Serag, H. B. (1998) · Digestive Diseases and Sciences · doi:10.1023/a:1018874516807 · Cited by 31 · see citing works
Common Errors and Controversies in Pharmacoeconomic Analyses
Byford, S., & Palmer, S. (1998) · PharmacoEconomics · doi:10.2165/00019053-199813060-00002 · Cited by 31 · see citing works
The Danish Approach to Standards For Economic Evaluation Methodologies
Alban, A., Gyldmark, M., Pedersen, A. V., & Søgaard, J. (1997) · PharmacoEconomics · doi:10.2165/00019053-199712060-00003 · Cited by 30 · see citing works
Economic Analysis of Alternative Treatments for Persistent Gastro-Oesophageal Reflux Disease
Hillman, A. L. (1994) · Scandinavian Journal of Gastroenterology · doi:10.3109/00365529409105374 · Cited by 28 · see citing works
Stal, J. M., Gregor, J. C., Preiksaitis, H. G., & Reynolds, R. P. E. (1998) · Canadian Journal of Gastroenterology · doi:10.1155/1998/947087 · Cited by 27 · see citing works
Zagari, M. J., Villa, K. F., & Freston, J. W. (1995) · The American Journal of Managed Care · Cited by 23 · see citing works
Economic analysis of step‐wise treatment of gastro‐oesophageal reflux disease
Sonnenberg, Inadomi, J. M., & Becker (1999) · Alimentary Pharmacology & Therapeutics · doi:10.1046/j.1365-2036.1999.00590.x · Cited by 22 · see citing works
Omeprazole or Ranitidine Plus Metoclopramide for Patients with Severe Erosive Oesophagitis
Bloom, B. S., Hillman, A. L., LaMont, B., Liss, C. L., Schwartz, J. S., & Stever, G. J. (1995) · PharmacoEconomics · doi:10.2165/00019053-199508040-00008 · Cited by 20 · see citing works
Pharmacoeconomic Models in Disease Management
Milne, R. J. (1998) · Disease Management & Health Outcomes · doi:10.2165/00115677-199804030-00001 · Cited by 20 · see citing works
Evaluating the quality of published pharmacoeconomic evaluations.
Sanchez, L. A. (1995) · PubMed · Cited by 18 · see citing works
Ofman, J. J., Yamashita, B. D., Siddique, R. M., Larson, L. R., & Willian, M. (2000) · PubMed · Cited by 17 · see citing works
Self-citationCost and Quality Effects of Treating Erosive Oesophagitis
Bloom, B. S. (1995) · PharmacoEconomics · doi:10.2165/00019053-199508020-00005 · Cited by 14 · see citing works
Omeprazole vs Ranitidine in Reflux Oesophagitis in Sweden
Lindberg, G. (1994) · PharmacoEconomics · doi:10.2165/00019053-199400053-00006 · Cited by 14 · see citing works
Cost-effectiveness of vinorelbine alone or vinorelbine plus cisplatin for stage IV NSCLC.
Evans, W. K. (1998) · PubMed · Cited by 13 · see citing works
Goetghebeur, M. M., & Rindress, D. (1999) · Value in Health · doi:10.1046/j.1524-4733.1999.24002.x · Cited by 11 · see citing works
Atherly, D., Sullivan, S., Fullerton, D., & Sturm, L. (2001) · Value in Health · doi:10.1046/j.1524-4733.2001.40201-15.x · Cited by 5 · see citing works
Self-citation
Flagged first, then by citations
2 of the 76 references couldn’t be matched to a known paper.
Research works printed but not linked: 19
- Shaneyfelt TM, Mayo-Smith MF, Rothwangl J. Are guidelines following guide- lines? The methodological quality of clinical practice guidelines in the peer- reviewed medical literature. JAMA. 1999;281:1900-05.
- Drummond MF, Richardson WS, O'Brien BJ, et al. User' s guide to the medical literature. XIII. How to use an article on economic analysis of clinical practice. A. Are the results of the study valid? Evidence-Based Medicine Working Group. JAMA. 1997; 277:1552-57.
- O'Brien B, Heyland D, Richardson WS, et al. User' s guide to the medical litera- ture. XIII. How to use an article on economic analysis of clinical practice. B. What are the results and will they help me in caring for my patients? JAMA.1997; 277:1802-06.
- Sonnenberg A, Inadomi JM, Becker LA. Economic analysis of step-wise treat- ment of gastroesophageal reflux disease. Aliment Pharmacol Ther. 1999;13:1003-13.
- Stalhammar NO. Assessing the cost-effectiveness of medical treatments in Examining the Value and Quality of Health Economic Analyses: Implications of Utilizing the QHES acid-related diseases. The Markov chain approach applied to a comparison between intermittent and maintenance treatment of reflux esophagitis. Scand J Gastroenterol Suppl. 1993;199:8-13.
- Bate C, Richardson P. Cost-effectiveness of omeprazole in the management of gastroesophageal reflux disease in clinical practice. Br J Med Econ. 1994;7:81-97.
- Bate C, Hungin A, Wilcock C. Cost-effective management of gastroesophageal reflux disease in general practice. Br J Med Econ. 1993;6:81-90.
- Bate C, Green J, Taylor M. Cost-effective prophylaxis against the recurrence of benign oesophageal stricture. Br J Med Econ. 1995;8:97-107.
- Bate C, Richardson P. A one-year model for the cost-effectiveness of treating reflux oesophagitis. Br J Med Econ. 1992;2:5-11.
- Bate C. Cost-effectiveness of omeprazole in the treatment of reflux oesophagi- tis. Br J Med Econ. 1991;1:53-61.
- Bate C, Richardson P. Symptomatic assessment and cost effectiveness of treat- ments for reflux oesophagitis: comparisons of omeprazole and histamine H2- receptor antagonists. Br J Med Econ. 1992;2:37-48.
- Green J, Bate C, Copeman M. A comparison of the cost-effectiveness of omeprazole and ranitidine in reflux oesophagitis. Br J Med Econ. 1995;8:37-48.
- Jonsson B, Stalhammar NO. The cost-effectiveness of omeprazole and raniti- dine in intermittent and maintenance treatment of reflux oesophagitis-the case of Sweden. Br J Med Econ. 1993;6:111-26.
- Phillips C, Moore A. Trial and error-an expensive luxury: economic analysis of effectiveness of proton pump inhibitors and histamine antagonists in treating reflux disease. Br J Med Econ. 1997;11:55-63.
- Bate C, Richardson P. Cost-effectiveness of 20 mg and 40 mg of omeprazole in oesophageal reflux disease. Br J Med Econ. 1993;6:59-66.
- Torrance GW, Blaker D, Detsky A, et al. Canadian guidelines for economic evaluation of pharmaceuticals. Canadian Collaborative Workshop for Pharmacoeconomics. Pharmacoeconomics. 1996;9:535-59.
- Economic analysis of health care technology. A report on principles. Task Force on Principles for Economic Analysis of Health Care Technology. Ann Intern Med. 1995;123:61-70.
- Drummond M, O'Brien B, Stoddart G, Torrance GW. Critical Assessment of Economic Evaluation. Methods for the Economic Evaluation of Health Care Programmes. Oxford, England: Oxford Medical Publications; 1997:27-51.
- Drummond MF, Jefferson TO. Guidelines for authors and peer reviewers of economic submissions to the BMJ. BMJ. 1996;313:275-83.
Cited by
Sorted by citations
ACC/AHA Statement on Cost/Value Methodology in Clinical Practice Guidelines and Performance Measures
Anderson, J. L., Heidenreich, P. A., Barnett, P. G., Creager, M. A., Fonarow, G. C., Gibbons, R. J., Halperin, J. L., Hlatky, M. A., Jacobs, A. K., Mark, D. B., et al. (2014) · Circulation · doi:10.1161/cir.0000000000000042 · Cited by 520 · see citing works
ACC/AHA Statement on Cost/Value Methodology in Clinical Practice Guidelines and Performance Measures
Anderson, J. L., Heidenreich, P. A., Barnett, P. G., Creager, M. A., Fonarow, G. C., Gibbons, R. J., Halperin, J. L., Hlatky, M. A., Jacobs, A. K., Mark, D. B., et al. (2014) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2014.03.016 · Cited by 442 · see citing works
Quality of primary care by advanced practice nurses: a systematic review
Swan, M., Ferguson, S., Chang, A., Larson, E., & Smaldone, A. M. (2015) · International Journal for Quality in Health Care · doi:10.1093/intqhc/mzv054 · Cited by 339 · see citing works
Hiligsmann, M., Cooper, C. C., Arden, N., Boers, M., Branco, J., Brandi, M. L., Bruyère, O., Guillemin, F., Hochberg, M. C., Hunter, D. J., et al. (2013) · Seminars in Arthritis and Rheumatism · doi:10.1016/j.semarthrit.2013.07.003 · Cited by 328 · see citing works
The costs and benefits of biochar production and use: A systematic review
Campion, L., Bekchanova, M., Malina, R. M., & Kuppens, T. E. (2023) · Journal of Cleaner Production · doi:10.1016/j.jclepro.2023.137138 · Cited by 301 · see citing works
Le, L. K., Esturas, A. C., Mihalopoulos, C., Chiotelis, O., Bucholc, J., Chatterton, M. L., & Engel, L. (2021) · PLoS Medicine · doi:10.1371/journal.pmed.1003606 · Cited by 259 · see citing works
Martin-Misener, R., Harbman, P., Donald, F., Reid, K., Kilpatrick, K., Carter, N., Bryant-Lukosius, D., Kaasalainen, S., Marshall, D. A., Charbonneau-Smith, R., et al. (2015) · BMJ Open · doi:10.1136/bmjopen-2014-007167 · Cited by 252 · see citing works
Cost-Effectiveness of Hypertension Therapy According to 2014 Guidelines
Moran, A. E., Odden, M. C., Thanataveerat, A., Tzong, K. Y., Rasmussen, P. W., Guzman, D., Williams, L. W., Bibbins-Domingo, K. B., Coxson, P. G., & Goldman, L. (2015) · New England Journal of Medicine · doi:10.1056/nejmsa1406751 · Cited by 237 · see citing works
Evidence and Value: Impact on DEcisionMaking – the EVIDEM framework and potential applications
Goetghebeur, M. M., Wagner, M., Khoury, H., Levitt, R. J., Erickson, L. J., & Rindress, D. (2008) · BMC Health Services Research · doi:10.1186/1472-6963-8-270 · Cited by 232 · see citing works
Leenen, J. P. L., Leerentveld, C., van Dijk, J. D., van Westreenen, H. L., Schoonhoven, L., & Patijn, G. A. (2020) · Journal of Medical Internet Research · doi:10.2196/18636 · Cited by 224 · see citing works
Economic Evaluations of Clinical Pharmacy Services: 2006–2010
Touchette, D. R., Doloresco, F., Suda, K. J., Pérez, A., Turner, S. J., Jalundhwala, Y. J., Tangonan, M. C., & Hoffman, J. M. (2014) · Pharmacotherapy The Journal of Human Pharmacology and Drug Therapy · doi:10.1002/phar.1414 · Cited by 222 · see citing works
ASHP Guidelines on the Pharmacy and Therapeutics Committee and the Formulary System
Tyler, L. S., Cole, S. W., May, J. R., Millares, M., Valentino, M. A., Vermeulen, L. C., & Wilson, A. L. (2008) · American Journal of Health-System Pharmacy · doi:10.2146/ajhp080086 · Cited by 208 · see citing works
Davis, J. C., Robertson, M. C., Ashe, M. C., Liu-Ambrose, T., Khan, K. M., & Marra, C. A. (2010) · British Journal of Sports Medicine · doi:10.1136/bjsm.2008.060988 · Cited by 198 · see citing works
Morris, S., Alsaidi, A. T., Verbyla, A., Cruz, A., Macfarlane, C., Bauer, J. E., & Patel, J. N. (2022) · Clinical Pharmacology & Therapeutics · doi:10.1002/cpt.2754 · Cited by 184 · see citing works
Kamaruzaman, H. F., Kinghorn, P., & Oppong, R. (2017) · BMC Musculoskeletal Disorders · doi:10.1186/s12891-017-1540-2 · Cited by 182 · see citing works
Roberts, S. L. E., Healey, A., & Sevdalis, N. (2019) · Implementation Science · doi:10.1186/s13012-019-0901-7 · Cited by 161 · see citing works
Growth and Quality of the Cost–Utility Literature, 1976–2001
Neumann, P. J., Greenberg, D., Olchanski, N., Stone, P. W., & Rosen, A. B. (2005) · Value in Health · doi:10.1111/j.1524-4733.2005.04010.x · Cited by 161 · see citing works
Self-citationBryant‐Lukosius, D., Carter, N., Reid, K. J., Donald, F., Martin‐Misener, R., Kilpatrick, K., Harbman, P., Kaasalainen, S., Marshall, D. A., Charbonneau-Smith, R., et al. (2015) · Journal of Evaluation in Clinical Practice · doi:10.1111/jep.12401 · Cited by 142 · see citing works
Kristensen, F. B., Husereau, D., Huić, M., Drummond, M., Berger, M. L., Bond, K., Augustovski, F., Booth, A., Bridges, J. F. P., Grimshaw, J., et al. (2018) · Value in Health · doi:10.1016/j.jval.2018.08.010 · Cited by 125 · see citing works
Current Status of Cost Utility Analyses in Total Joint Arthroplasty: A Systematic Review
Nwachukwu, B. U., Bozic, K. J., Schairer, W. W., Bernstein, J. L., Jevsevar, D. S., Marx, R. G., & Padgett, D. E. (2014) · Clinical Orthopaedics and Related Research · doi:10.1007/s11999-014-3964-4 · Cited by 114 · see citing works
Cost Effectiveness of Pharmacogenomics
Wong, W. B., Carlson, J. J., Thariani, R., & Veenstra, D. L. (2010) · PharmacoEconomics · doi:10.2165/11537410-000000000-00000 · Cited by 108 · see citing works
Health Outcomes and Costs of Social Work Services: A Systematic Review
Steketee, G. S., Ross, A. M., & Wachman, M. K. (2017) · American Journal of Public Health · doi:10.2105/ajph.2017.304004 · Cited by 109 · see citing works
Kilpatrick, K., Kaasalainen, S., Donald, F., Reid, K., Carter, N., Bryant‐Lukosius, D., Martin‐Misener, R., Harbman, P., Marshall, D. A., Charbonneau‐Smith, R., et al. (2014) · Journal of Evaluation in Clinical Practice · doi:10.1111/jep.12219 · Cited by 98 · see citing works
Rouzier, R., Pronzato, P., Chereau, E., Carlson, J. J., Hunt, B., & Valentine, W. J. (2013) · Breast Cancer Research and Treatment · doi:10.1007/s10549-013-2559-1 · Cited by 95 · see citing works
Spiegel, B. M. R., Targownik, L. E., Kanwal, F., DeRosa, V. P., Dulai, G. S., Gralnek, I. M., & Chiou, C. (2004) · Gastroenterology · doi:10.1053/j.gastro.2004.04.020 · Cited by 95 · see citing works
Self-citationFuture Directions for Cost-effectiveness Analyses in Health and Medicine
Neumann, P. J., Kim, D. D., Trikalinos, T. A., Sculpher, M. J., Salomon, J. A., Prosser, L. A., Owens, D. K., Meltzer, D. O., Kuntz, K. M., Krahn, M. D., et al. (2018) · Medical Decision Making · doi:10.1177/0272989x18798833 · Cited by 94 · see citing works
Self-citationPinto, D., Robertson, M. C., Hansen, P., & Abbott, J. H. (2012) · Value in Health · doi:10.1016/j.jval.2011.09.003 · Cited by 94 · see citing works
Challenges in Systematic Reviews of Economic Analyses
Pignone, M. P., Saha, S., Hoerger, T. J., Lohr, K. N., Teutsch, S. M., & Mandelblatt, J. (2005) · Annals of Internal Medicine · doi:10.7326/0003-4819-142-12_part_2-200506211-00007 · Cited by 94 · see citing works
McQueen, R. B., Sheehan, D. N., Whittington, M. D., van Boven, J. F. M., & Campbell, J. D. (2018) · PharmacoEconomics · doi:10.1007/s40273-018-0658-x · Cited by 94 · see citing works
Costs and Cost-Effectiveness of Malaria Control Interventions: A Systematic Literature Review
Conteh, L., Shuford, K. V., Agboraw, E., Kont, M. D., Kolaczinski, J. H., & Patouillard, E. (2021) · Value in Health · doi:10.1016/j.jval.2021.01.013 · Cited by 96 · see citing works
Wang, S., Dang, W., Richman, I. B., Mougalian, S. S., Evans, S. B., & Gross, C. P. (2018) · Journal of Clinical Oncology · doi:10.1200/jco.2017.76.5941 · Cited by 88 · see citing works
The ISPOR Good Practices for Quality Improvement of Cost-Effectiveness Research Task Force Report
McGhan, W. F., Al, M., Doshi, J. A., Kamae, I., Marx, S. E., & Rindress, D. (2009) · Value in Health · doi:10.1111/j.1524-4733.2009.00605.x · Cited by 84 · see citing works
Doan, Q. V., Chiou, C., & Dubois, R. W. (2006) · Journal of Managed Care Pharmacy · doi:10.18553/jmcp.2006.12.7.555 · Cited by 84 · see citing works
Self-citationCost-efficacy of Knee Cartilage Defect Treatments in the United States
Everhart, J. S., Campbell, A. B., Abouljoud, M. M., Kirven, J. C., & Flanigan, D. C. (2019) · The American Journal of Sports Medicine · doi:10.1177/0363546519834557 · Cited by 76 · see citing works
Economic evaluations of comprehensive geriatric assessment in surgical patients: a systematic review
Eamer, G., Saravana-Bawan, B. B., van der Westhuizen, B., Chambers, T., Ohinmaa, A. E., & Khadaroo, R. G. (2017) · Journal of Surgical Research · doi:10.1016/j.jss.2017.03.041 · Cited by 73 · see citing works
Cost analyses of obesity in Canada: scope, quality, and implications
Tran, B. X., Nair, A. V., Kuhle, S., Ohinmaa, A. E., & Veugelers, P. J. (2013) · Cost Effectiveness and Resource Allocation · doi:10.1186/1478-7547-11-3 · Cited by 72 · see citing works
Donald, F., Kilpatrick, K., Reid, K. J., Carter, N., Bryant‐Lukosius, D., Martin‐Misener, R., Kaasalainen, S., Harbman, P., Marshall, D. A., & DiCenso, A. (2014) · International Journal of Nursing Studies · doi:10.1016/j.ijnurstu.2014.07.011 · Cited by 71 · see citing works
Agarwal, N., To, K., & Khan, W. S. (2020) · International Journal of Clinical Practice · doi:10.1111/ijcp.13806 · Cited by 69 · see citing works
Freijer, K., Bours, M. J. L., Nuijten, M. J. C., Poley, M. J., Meijers, J. M. M., Halfens, R. J. G., & Schols, J. M. G. A. (2013) · Journal of the American Medical Directors Association · doi:10.1016/j.jamda.2013.09.005 · Cited by 67 · see citing works
Timing of Decompressive Surgery in Patients With Acute Spinal Cord Injury: Systematic Review Update
Fehlings, M. G., Hachem, L. D., Tetreault, L. A., Skelly, A. C., Dettori, J. R., Brodt, E., Stabler-Morris, S., Redick, B. J., Evaniew, N., Martin, A. R., et al. (2024) · Global Spine Journal · doi:10.1177/21925682231197404 · Cited by 63 · see citing works
Cost Effectiveness of Treatments for Diabetic Retinopathy: A Systematic Literature Review
Maniadakis, N., & Konstantakopoulou, E. (2019) · PharmacoEconomics · doi:10.1007/s40273-019-00800-w · Cited by 63 · see citing works
Statistical Methods for Cost-Effectiveness Analyses That Use Data from Cluster Randomized Trials
Gomes, M., Grieve, R., Nixon, R. M., & Edmunds, W. J. (2011) · Medical Decision Making · doi:10.1177/0272989x11407341 · Cited by 60 · see citing works
Cost-Effectiveness Analyses in Orthopaedic Sports Medicine
Nwachukwu, B. U., Schairer, W. W., Bernstein, J. L., Dodwell, E. R., Marx, R. G., & Allen, A. A. (2014) · The American Journal of Sports Medicine · doi:10.1177/0363546514544684 · Cited by 60 · see citing works
A systematic review of cost-effectiveness of monoclonal antibodies for metastatic colorectal cancer
Lange, A., Prenzler, A., Frank, M. R., Kirstein, M. M., Vogel, A., & von der Schulenburg, J. G. (2013) · European Journal of Cancer · doi:10.1016/j.ejca.2013.08.008 · Cited by 59 · see citing works
A Systematic Review of the Cost Effectiveness of Herpes Zoster Vaccination
Szucs, T. D., & Pfeil, A. M. (2013) · PharmacoEconomics · doi:10.1007/s40273-012-0020-7 · Cited by 59 · see citing works
Donald, F., Kilpatrick, K., Reid, K., Carter, N., Martin-Misener, R., Bryant-Lukosius, D., Harbman, P., Kaasalainen, S., Marshall, D. A., Charbonneau-Smith, R., et al. (2014) · Nursing Research and Practice · doi:10.1155/2014/896587 · Cited by 59 · see citing works
Economic Outcomes of Treatment for Ureteral and Renal Stones: A Systematic Literature Review
Matlaga, B. R., Jansen, J. P., Meckley, L. M., Byrne, T. W., & Lingeman, J. E. (2012) · The Journal of Urology · doi:10.1016/j.juro.2012.04.008 · Cited by 59 · see citing works
Cost-effectiveness Analyses of Antihypertensive Medicines: A Systematic Review
Park, C., Wang, G., Durthaler, J. M., & Fang, J. (2017) · American Journal of Preventive Medicine · doi:10.1016/j.amepre.2017.06.020 · Cited by 59 · see citing works
Cell Therapy for Treatment of Intervertebral Disc Degeneration: A Systematic Review
Meisel, H.-J., Agarwal, N. P., Hsieh, P. C., Skelly, A. C., Park, J., Brodke, D. S., Wang, J. C., Yoon, S. T., & Buser, Z. (2019) · Global Spine Journal · doi:10.1177/2192568219829024 · Cited by 58 · see citing works
Patient-level costs in margin re-excision for breast-conserving surgery
Grant, Y., Al-Khudairi, R., John, E. S., Barschkett, M., Cunningham, D., Al-Mufti, R., Hogben, K. R., Thiruchelvam, P. T. R., Hadjiminas, D. J., Darzi, A. W., et al. (2018) · British journal of surgery · doi:10.1002/bjs.11050 · Cited by 57 · see citing works
Limone, B. L., Baker, W. L., Kluger, J., & Coleman, C. I. (2013) · PLoS ONE · doi:10.1371/journal.pone.0062183 · Cited by 57 · see citing works
Assessment of the Quality of Cost Analysis Literature in Physical Therapy
Peterson, L. E., Goodman, C. S., Karnes, E. K., Chen, C. J., & Schwartz, J. A. (2009) · Physical Therapy · doi:10.2522/ptj.20080326 · Cited by 53 · see citing works
Economic analyses of human genetics services: A systematic review
Carlson, J. J., Henrikson, N. B., Veenstra, D. L., & Ramsey, S. D. (2005) · Genetics in Medicine · doi:10.1097/01.gim.0000182467.79495.e2 · Cited by 55 · see citing works
Management of End-Stage Ankle Arthritis: Cost-Utility Analysis Using Direct and Indirect Costs
Nwachukwu, B. U., McLawhorn, A. S., Simon, M. S., Hamid, K. S., Demetracopoulos, C. A., Deland, J. T., & Ellis, S. J. (2015) · Journal of Bone and Joint Surgery · doi:10.2106/jbjs.n.01215 · Cited by 54 · see citing works
Lopatina, E., Donald, F., DiCenso, A., Martin‐Misener, R., Kilpatrick, K., Bryant‐Lukosius, D., Carter, N., Reid, K. J., & Marshall, D. A. (2017) · International Journal of Nursing Studies · doi:10.1016/j.ijnurstu.2017.04.012 · Cited by 53 · see citing works
Farbman, L., Avni, T., Rubinovitch, B., Leibovici, L., & Paul, M. (2013) · Clinical Microbiology and Infection · doi:10.1111/1469-0691.12280 · Cited by 48 · see citing works
Beynon, R. A., Hawkins, J. E., Laing, R. J. C., Higgins, N., Whiting, P. F., Jameson, C., Sterne, J. A. C., Vergara, P., & Hollingworth, W. (2013) · Health Technology Assessment · doi:10.3310/hta17190 · Cited by 48 · see citing works
Winser, S. J., Chan, H. T. F., Ho, L., Chung, L. S., Ching, L. T., Lok, T. F., & Kannan, P. (2019) · Annals of Physical and Rehabilitation Medicine · doi:10.1016/j.rehab.2019.06.012 · Cited by 44 · see citing works
Nshimyumukiza, L., Menon, S., Hina, H., Rousseau, F., & Reinharz, D. (2017) · Clinical Genetics · doi:10.1111/cge.13155 · Cited by 46 · see citing works
ASHP Guidelines on the Pharmacy and Therapeutics Committee and the Formulary System
Ciccarello, C., Leber, M. B., Leonard, M. C., Nesbit, T. W., Petrovskis, M. G., Pherson, E. C., Pillen, H. A., Proctor, C., & Reddan, J. G. (2021) · American Journal of Health-System Pharmacy · doi:10.1093/ajhp/zxab080 · Cited by 45 · see citing works
de Oliveira, C., Cho, E., Kavelaars, R., Jamieson, M., Bao, B., & Rehm, J. (2020) · The Lancet Psychiatry · doi:10.1016/s2215-0366(20)30145-0 · Cited by 44 · see citing works
Health economics of rubella: a systematic review to assess the value of rubella vaccination
Babigumira, J. B., Morgan, I., & Levin, A. (2013) · BMC Public Health · doi:10.1186/1471-2458-13-406 · Cited by 44 · see citing works
Bürge, E., Monnin, D., Berchtold, A., & Allet, L. (2016) · Physical Therapy · doi:10.2522/ptj.20140333 · Cited by 44 · see citing works
Seo, M. K., & Cairns, J. (2018) · PLoS ONE · doi:10.1371/journal.pone.0204496 · Cited by 44 · see citing works
A Systematic Review of Scope and Quality of Health Economic Evaluation Studies in Vietnam
Tran, B. X., Nong, V. M., Maher, R. M., Nguyen, P. K., & Luu, H. N. (2014) · PLoS ONE · doi:10.1371/journal.pone.0103825 · Cited by 42 · see citing works
The cost effectiveness of palivizumab: a systematic review of the evidence
Smart, K. A., Lanctôt, K. L., & Paes, B. A. (2010) · Journal of Medical Economics · doi:10.3111/13696998.2010.499749 · Cited by 42 · see citing works
Al-Ziftawi, N. H., Shafie, A. A., & Ibrahim, M. I. M. (2020) · Expert Review of Pharmacoeconomics & Outcomes Research · doi:10.1080/14737167.2020.1794826 · Cited by 41 · see citing works
Yoo, K., Kwon, J. A., Cho, E., Kang, M. H., Nam, J.-M., Choi, K. S., Kim, E., Choi, Y. J., & Park, E. (2013) · Asian Pacific Journal of Cancer Prevention · doi:10.7314/apjcp.2013.14.7.4141 · Cited by 41 · see citing works
A framework for assessing Health Economic Evaluation (HEE) quality appraisal instruments
Langer, A. (2012) · BMC Health Services Research · doi:10.1186/1472-6963-12-253 · Cited by 41 · see citing works
The impact of ischaemic stroke on atrial fibrillation-related healthcare cost: a systematic review
Li, X., Tse, V. C., Au-Doung, P. L. W., Wong, I. C. K., & Chan, E. W. (2016) · EP Europace · doi:10.1093/europace/euw093 · Cited by 41 · see citing works
Cost analysis of telerehabilitation after arthroscopic subacromial decompression
Pastora‐Bernal, J., Martín‐Valero, R., & Barón-López, F. J. (2017) · Journal of Telemedicine and Telecare · doi:10.1177/1357633x17723367 · Cited by 41 · see citing works
Is Minimal Access Spine Surgery More Cost-effective Than Conventional Spine Surgery?
Lubelski, D., Mihalovich, K. E., Skelly, A. C., Fehlings, M. G., Harrop, J. S., Mummaneni, P. V., Wang, M. Y., & Steinmetz, M. P. (2014) · Spine · doi:10.1097/brs.0000000000000571 · Cited by 39 · see citing works
Reliability of Two Instruments for Critical Assessment of Economic Evaluations
Au, F., Prahardhi, S., & Shiell, A. (2007) · Value in Health · doi:10.1111/j.1524-4733.2007.00255.x · Cited by 39 · see citing works
Sukri, A., Salleh, M. Z., Masimirembwa, C. M., & Teh, L. K. (2022) · The Pharmacogenomics Journal · doi:10.1038/s41397-022-00272-w · Cited by 38 · see citing works
Lange, A., Prenzler, A., Frank, M., Golpon, H., Welte, T., & von der Schulenburg, J.-M. (2014) · BMC Pulmonary Medicine · doi:10.1186/1471-2466-14-192 · Cited by 38 · see citing works
Nwachukwu, B. U., Schairer, W. W., McCormick, F. M., Dines, D. M., Craig, E. V., & Gulotta, L. V. (2016) · Journal of Shoulder and Elbow Surgery · doi:10.1016/j.jse.2015.12.022 · Cited by 37 · see citing works
Cleemput, I., Wilder, P. V., Huybrechts, M., & Vrijens, F. (2008) · Value in Health · doi:10.1111/j.1524-4733.2008.00469.x · Cited by 37 · see citing works
The state of health economic and pharmacoeconomic evaluation research in Zimbabwe: A review
Gavaza, P., Rascati, K. L., Brown, C. M., Lawson, K. A., & Mann, T. A. (2008) · Current Therapeutic Research · doi:10.1016/j.curtheres.2008.06.005 · Cited by 36 · see citing works
Marshall, D. A., Donald, F., Lacny, S., Reid, K. J., Bryant‐Lukosius, D., Carter, N., Charbonneau-Smith, R., Harbman, P., Kaasalainen, S., Kilpatrick, K., et al. (2015) · NursingPlus Open · doi:10.1016/j.npls.2015.07.001 · Cited by 36 · see citing works
The State of Health Economic Evaluation Research in Nigeria
Gavaza, P., Rascati, K. L., Oladapo, A. O., & Khoza, S. (2010) · PharmacoEconomics · doi:10.2165/11536170-000000000-00000 · Cited by 35 · see citing works
Cao, J. Q., Rodrigues, G., Louie, A. V., & Zaric, G. S. (2011) · Clinical Lung Cancer · doi:10.1016/j.cllc.2011.09.002 · Cited by 35 · see citing works
Abraham, C. M., Norful, A. A., Stone, P. W., & Poghosyan, L. (2019) · PubMed · Cited by 35 · see citing works
Cost Analyses of Prosthetic Devices: A Systematic Review
Donnelley, C. A., Shirley, C., von Kaeppler, E. P., Hetherington, A. M., Albright, P., Morshed, S., & Shearer, D. (2021) · Archives of Physical Medicine and Rehabilitation · doi:10.1016/j.apmr.2021.02.010 · Cited by 34 · see citing works
AlMukdad, S., Elewa, H. F., & Al‐Badriyeh, D. (2020) · Journal of Cardiovascular Pharmacology and Therapeutics · doi:10.1177/1074248420902298 · Cited by 34 · see citing works
Cost-Effectiveness and Clinical Practice Guidelines: Have We Reached a Tipping Point?—An Overview
Garrison, L. P. (2016) · Value in Health · doi:10.1016/j.jval.2016.04.018 · Cited by 34 · see citing works
Economic Decision Model for First-Time Traumatic Patellar Dislocations in Adolescents
Nwachukwu, B. U., So, C., Schairer, W. W., Stein, B. E. S., Strickland, S. M., Green, D. W., & Dodwell, E. R. (2017) · The American Journal of Sports Medicine · doi:10.1177/0363546517703347 · Cited by 33 · see citing works
Evaluation and review of pharmacoeconomic models
Hay, J. (2004) · Expert Opinion on Pharmacotherapy · doi:10.1517/14656566.5.9.1867 · Cited by 37 · see citing works
Self-citationWettstein, D. J., & Boes, S. (2018) · Applied Health Economics and Health Policy · doi:10.1007/s40258-018-0437-z · Cited by 32 · see citing works
de Bot, R. T. A. L., Veldman, H. D., Witlox, A. M. A., van Rhijn, L. W., & Hiligsmann, M. (2020) · Osteoporosis International · doi:10.1007/s00198-019-05252-8 · Cited by 32 · see citing works
Laberge, M., Sirois, C., Lunghi, C., Gaudreault, M., Nakamura, Y., Bolduc, C., & Laroche, M. (2021) · Clinical Interventions in Aging · doi:10.2147/cia.s304074 · Cited by 32 · see citing works
Mukdad, M. A., Al‐Badriyeh, D., & Elewa, H. F. (2019) · Clinical and Applied Thrombosis/Hemostasis · doi:10.1177/1076029619849103 · Cited by 32 · see citing works
Alvin, M. D., Qureshi, S. A., Klineberg, E. O., Riew, K. D., Fischer, D. J., Norvell, D. C., & Mroz, T. E. (2014) · Spine · doi:10.1097/brs.0000000000000547 · Cited by 31 · see citing works
Cost-effectiveness of minimally invasive sacroiliac joint fusion
Cher, D., Frasco, M. A., Arnold, R. J. G., & Polly, D. W. (2015) · ClinicoEconomics and Outcomes Research · doi:10.2147/ceor.s94266 · Cited by 31 · see citing works
Is it a Chimera? A systematic review of the economic evaluations of CAR-T cell therapy
Petrou, P. (2019) · Expert Review of Pharmacoeconomics & Outcomes Research · doi:10.1080/14737167.2019.1651646 · Cited by 31 · see citing works
The State of Health Economic Research in South Africa
Gavaza, P., Rascati, K. L., Oladapo, A. O., & Khoza, S. (2012) · PharmacoEconomics · doi:10.2165/11589450-000000000-00000 · Cited by 31 · see citing works
The Quality of Cost-Utility Analyses in Orthopedic Trauma
Nwachukwu, B. U., Schairer, W. W., O’Dea, E. M., McCormick, F. M., & Lane, J. M. (2015) · Orthopedics · doi:10.3928/01477447-20150804-53 · Cited by 30 · see citing works
Katsigianni, E. I., & Petrou, P. (2022) · Cost Effectiveness and Resource Allocation · doi:10.1186/s12962-022-00369-w · Cited by 29 · see citing works
Risk of respiratory syncytial virus infection in preterm infants: reviewing the need for prevention
Abraha, H. Y., Lanctôt, K. L., & Paes, B. A. (2015) · Expert Review of Respiratory Medicine · doi:10.1586/17476348.2015.1098536 · Cited by 29 · see citing works
Luhnen, M., Prediger, B., Neugebauer, E. A. M., & Mathes, T. (2019) · Research Synthesis Methods · doi:10.1002/jrsm.1342 · Cited by 28 · see citing works
Methodologic Quality of Cost-Effectiveness Analyses of Surgical Procedures
Kruper, L. L., Kurichi, J. E., & Sonnad, S. S. (2006) · Annals of Surgery · doi:10.1097/01.sla.0000231802.83152.59 · Cited by 28 · see citing works
- Authors
- Ofman, J. J., Sullivan, S. D., Neumann, P. J., Chiou, C.-F., Henning, J. M., Wade, S. W., & Hay, J. W.
- Venue
- Journal of Managed Care Pharmacy
- Publisher
- Academy of Managed Care Pharmacy
- Published
- 2003-01
- Volume
- 9
- Issue
- 1
- Pages
- 53-61
- ISSN
- 1083-4087 (ISSN-L)
- 1944-706X
- PMC
- PMC10437166
- OpenAlex
- W2130921523
- Cited by
- 366
- References
- 76
- Citations by year
- 2026: 14 · 2025: 18 · 2024: 18 · 2023: 26 · 2022: 25 · 2021: 39 · 2020: 27 · 2019: 35 · 2018: 17 · 2017: 20 · 2016: 16 · 2015: 21 · 2014: 24 · 2013: 18 · 2012: 11
- FWCI
- 9.62
- Type
- journal article
- Language
- en
- Open access
- green
- www.ncbi.nlm.nih.gov
- Locations
- Journal of Managed Care Pharmacy (publishedVersion)
- PubMed Central (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Social Sciences › Economics, Econometrics and Finance › Economics and Econometrics › Health Systems, Economic Evaluations, Quality of Life
- Social Sciences › Decision Sciences › Statistics, Probability and Uncertainty › Meta-analysis and systematic reviews
- Social Sciences › Sociology and Political Science › Delphi Technique in Research
- Keywords
- instrument validation, gastroesophageal reflux disease, healthcare decision-making, resource allocation, reporting guidelines, systematic reviews
- MeSH terms
- Cost-Benefit Analysis, Delivery of Health Care, Humans, United States, Economics, Pharmaceutical
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
